3 Crushed REITs: Are They Bargains Or Yield Traps?
The oldest investing advice on Wall Street is to buy low and sell high. But the problem is that you never know for sure where the lowest or highest prices are.
Barclays Maintains Equal-Weight on Uniti Group, Lowers Price Target to $8
Barclays analyst Brendan Lynch maintains Uniti Group (NASDAQ:UNIT) with a Equal-Weight and lowers the price target from $9 to $8.
Wall Street’s Most Accurate Analysts Say Hold These 3 Real Estate Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
3 Low-Priced REITs With Big Recent Gains
Investors always want to buy low and sell high. Many dream of buying a low-priced stock and riding it up for gains of 50% or 100%.
Most Affordable Stocks In The Real Estate Sector: Uniti Group, CBL & Associates Properties And More
The most oversold stocks in the real estate sector presents an opportunity to buy into undervalued companies.
2 Cell Tower REITs With Above-Average Yields: A Great Buy During Coveted Fed Pivot?
SP Global data shows that, over a three-year period, cell tower real estate investment trusts (REITs) had the highest potential returns out of any other REIT sector of nearly 30%.
Stocks That Hit 52-Week Lows On Thursday
During Thursday's trading, 138 companies set new 52-week lows.
Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC met the primary endpoint.
